COMPANY

Accel Diagnostics

Accel Diagnostic Laboratories (Accel Lab) is a provider of medical laboratory and diagnostic testing services with an extensive network. From company website Source · Oct 12, 2026

Keywords: diagnostics

Profile checked Oct 10, 2026

15NIH grants

NIH awards 15

Annual award amounts. Total $5.0M.

Feb 5, 2024 NIH award 5R44AI157776-04 FY2024: $398,753 awarded for that fiscal year; activity R44 (SBIR); PI GANDINI, ALBERTO; recipient as written: ACCEL DIAGNOSTICS, LLC, Houston, TX. A COVID-19 Point of Care Serological Assay source ↗
Apr 20, 2023 NIH award 5R44AI157776-03 FY2023: $97,316 awarded for that fiscal year; activity R44 (SBIR); PI GANDINI, ALBERTO; recipient as written: ACCEL DIAGNOSTICS, LLC, Houston, TX. A COVID-19 Point of Care Serological Assay source ↗
Feb 16, 2022 NIH award 4R44AI157776-02 FY2022: $963,581 awarded for that fiscal year; activity R44 (SBIR); PI GANDINI, ALBERTO; recipient as written: ACCEL DIAGNOSTICS, LLC, Houston, TX. A COVID-19 Point of Care Serological Assay source ↗
Feb 3, 2021 NIH award 1R44AI157776-01 FY2021: $240,405 awarded for that fiscal year; activity R44 (SBIR); PI GANDINI, ALBERTO; recipient as written: ACCEL DIAGNOSTICS, LLC, Houston, TX. A COVID-19 Point of Care Serological Assay source ↗
Aug 25, 2020 NIH award 1R43NS115309-01A1 FY2020: $223,966 awarded for that fiscal year; activity R43 (SBIR); PI GANDINI, ALBERTO; recipient as written: ACCEL DIAGNOSTICS, LLC, Houston, TX. A rapid blood test to aid the triage of source ↗
Feb 26, 2019 NIH award 1R43HD097888-01A1 FY2019: $215,450 awarded for that fiscal year; activity R43 (SBIR); PI GANDINI, ALBERTO; recipient as written: ACCEL DIAGNOSTICS, LLC, Houston, TX. A Rapid Non-Invasive Device for Monitori source ↗
2019 NIH contract (government contract; not a grant and not an investment round) 75N92019C00002-0-9999-1 FY2019: $727,427 awarded for that fiscal year; activity N44 (OTHER_NIH); PI GANDINI, ALBERTO; recipient as written: ACCEL DIAGNOSTICS, LLC, Houston, TX. SBIR To source ↗
Jul 26, 2018 NIH award 5R44HL127880-03 FY2018: $331,659 awarded for that fiscal year; activity R44 (SBIR); PI GANDINI, ALBERTO; recipient as written: ACCEL DIAGNOSTICS, LLC, Houston, TX. A disposable assay for the monitoring of h source ↗
Aug 7, 2017 NIH award 2R44HL127880-02A1 FY2017: $611,965 awarded for that fiscal year; activity R44 (SBIR); PI GANDINI, ALBERTO; recipient as written: ACCEL DIAGNOSTICS, LLC, Houston, TX. A disposable assay for the monitoring of source ↗
Apr 5, 2017 NIH award 3R43AI125013-01S1 FY2017: $49,046 awarded for that fiscal year; activity R43 (SBIR); PI GANDINI, ALBERTO; recipient as written: ACCEL DIAGNOSTICS, LLC, Houston, TX. I-Corps Program for A rapid instrument-fr source ↗
Jun 14, 2016 NIH award 1R43AI125013-01 FY2016: $145,499 awarded for that fiscal year; activity R43 (SBIR); PI GANDINI, ALBERTO; recipient as written: ACCEL DIAGNOSTICS, LLC, Houston, TX. A rapid instrument-free diagnostic assay f source ↗
2016 NIH contract (government contract; not a grant and not an investment round) 268201600027C-0-0-1 FY2016: $212,552 awarded for that fiscal year; activity N01 (OTHER_NIH); PI GANDINI, ALBERTO; recipient as written: ACCEL DIAGNOSTICS, LLC, Houston, TX. SBIR Topic source ↗
Mar 23, 2015 NIH award 1R43HL127880-01 FY2015: $225,133 awarded for that fiscal year; activity R43 (SBIR); PI GANDINI, ALBERTO; recipient as written: ACCEL DIAGNOSTICS, LLC, Houston, TX. A disposable assay for the monitoring of h source ↗
Aug 1, 2013 NIH award 5R43HL110508-02 FY2013: $168,846 awarded for that fiscal year; activity R43 (SBIR); PI GANDINI, ALBERTO; recipient as written: ACCEL DIAGNOSTICS, LLC, Houston, TX. Blood Filtration System for the Treatment source ↗
Aug 16, 2012 NIH award 1R43HL110508-01A1 FY2012: $355,563 awarded for that fiscal year; activity R43 (SBIR); PI GANDINI, ALBERTO; recipient as written: ACCEL DIAGNOSTICS, LLC, Houston, TX. Blood Filtration System for the Treatmen source ↗